ECNP Congress 2022
The mission of the ECNP Congress is to bring together under one roof all the many pieces that go to make up the CNS treatment puzzle – from the lab all the way to the pharmacy and clinic.
ECNP would therefore like to invite companies and organisations involved in clinical and pre-clinical research, diagnosis and treatment of disorders of the brain to contribute to the congress’s educational function, by allowing participants to gain access to your high-quality information and advice, services, products and literature.
The deadline to apply for industry sessions is 18 January 2022.
The exhibition deadline for initial application (to be considered in the initial assignment of stand space at the Vienna venue) will be 18 January 2022. After this initial stand space assignment, the remaining space will be allocated to later applications until 1 July 2022. No stand applications or additional packages can be accepted after 1 July 2022.
More content available within our dedicated Learning Zones and Speciality Hubs
Neurology (CNS) and Pain
Learning materials and guidelines on Neurology (CNS) and Pain.
One Neuroscience and Pain Learning Zone
A focus on ADHD, Alzheimer's disease, epilepsy and pain. Videos within each section, world-leading experts will help you diagnose these often challenging conditions.
Multiple Sclerosis (MS) Learning Zone
Choosing the right treatment is critical to managing multiple sclerosis (MS). Consider your options with the latest data from over 40 MS clinical trial and congress resources.
Major depressive disorder and treatment-resistant depression
The treatment landscape for major depressive disorder (MDD) and treatment-resistant depression (TRD) is evolving, with recent approvals impacting on treatment algorithms.
Innovation in MS: working towards better disease management
Watch footage from our recent webinar, sponsored by Merck KGaA, Darmstadt, Germany, to learn from an internationally renowned faculty about some of the innovations in MS